Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122081213 | 12208121 | 3 | F | 2016 | 20160817 | 20160324 | 20160824 | PER | US-CELGENEUS-USA-2016035332 | CELGENE | 74.68 | YR | M | Y | 0.00000 | 20160824 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122081213 | 12208121 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | U | B2005AA,B2005AB | 20785 | 100 | MG | CAPSULES | QD | |||||
| 122081213 | 12208121 | 2 | SS | THALOMID | THALIDOMIDE | 1 | Oral | U | B2005AA,B2005AB | 20785 | 100 | MG | CAPSULES | QD | |||||
| 122081213 | 12208121 | 3 | SS | THALOMID | THALIDOMIDE | 1 | Oral | U | B2005AA,B2005AB | 20785 | 100 | MG | CAPSULES | QD | |||||
| 122081213 | 12208121 | 4 | C | KLOR-CON | POTASSIUM CHLORIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 122081213 | 12208121 | 5 | C | ZESTORETIC | HYDROCHLOROTHIAZIDELISINOPRIL | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 122081213 | 12208121 | 6 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MILLIGRAM | 0 | 40 | MG | UNKNOWN | QD | ||||||
| 122081213 | 12208121 | 7 | C | TERAZOSIN | TERAZOSINTERAZOSIN HYDROCHLORIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 122081213 | 12208121 | 8 | C | Integra | 2 | Unknown | 1 TABLET | 0 | 1 | DF | TABLETS | QD | |||||||
| 122081213 | 12208121 | 9 | C | HYDROCHLOROTHIAZIDE AND LISINOPRIL | HYDROCHLOROTHIAZIDELISINOPRIL | 1 | Unknown | 0 | 1 | DF | TABLETS | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122081213 | 12208121 | 1 | Prostatitis |
| 122081213 | 12208121 | 2 | Anaemia |
| 122081213 | 12208121 | 3 | Gastrointestinal haemorrhage |
| 122081213 | 12208121 | 4 | Product used for unknown indication |
| 122081213 | 12208121 | 5 | Product used for unknown indication |
| 122081213 | 12208121 | 6 | Peptic ulcer |
| 122081213 | 12208121 | 7 | Product used for unknown indication |
| 122081213 | 12208121 | 8 | Anaemia |
| 122081213 | 12208121 | 9 | Coronary artery disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122081213 | 12208121 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122081213 | 12208121 | Constipation | |
| 122081213 | 12208121 | Depression | |
| 122081213 | 12208121 | Dizziness postural |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122081213 | 12208121 | 1 | 201601 | 0 | ||
| 122081213 | 12208121 | 2 | 20160224 | 0 | ||
| 122081213 | 12208121 | 3 | 20160603 | 0 |